A Preliminary Clinical Study to Evaluate Fispemifene in the Treatment of Hypogonadism
A Preliminary Clinical Study to Evaluate Fispemifene in the Treatment of Hypogonadism
The purpose of this study is to determine whether one or more fispemifene dose regimens are
 more effective than placebo in the treatment of hypogonadism in older men.
Inclusion Criteria:

 -  Total testosterone level <240 ng/dL

 -  Serum LH and FSH levels within normal limits

 Exclusion Criteria:

 -  Elevated prolactin

 -  Evidence of Benign Prostatic Hypertrophy

 -  History of or current breast cancer, prostate cancer, abnormal DRE or elevated PSA or
 any other malignancy

 -  Clinically significant endocrine/metabolic or cardiovascular disease

 -  Significant polycythemia